Goldman Sachs’s Equillium EQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-218,162
Closed -$1.28M 6303
2021
Q2
$1.28M Buy
+218,162
New +$1.37M ﹤0.01% 4571
2021
Q1
Sell
-15,621
Closed -$84K 6139
2020
Q4
$84K Buy
+15,621
New +$81.6K ﹤0.01% 5318
2020
Q3
Sell
-471,146
Closed -$1.39M 5366
2020
Q2
$1.39M Sell
471,146
-61,634
-12% -$175K ﹤0.01% 3732
2020
Q1
$1.44M Sell
532,780
-55,619
-9% -$239K ﹤0.01% 3509
2019
Q4
$1.99M Buy
+588,399
New +$2.21M ﹤0.01% 3648

Other funds holding EQ

Goldman Sachs's EQ Position: Q3 2021 in Review

Goldman Sachs sold out of Equillium (EQ) in Q3 2021, closing a stake of 218,162 shares — an estimated $1.28M sold.

Goldman Sachs first reported a position in EQ in Q4 2019 and held it in 5 quarters. The position peaked at $1.99M in Q4 2019. 22 funds tracked by Wall St. Rank hold EQ as of Q3 2021.

  • Goldman Sachs reported no remaining Equillium position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 218,162 Equillium shares in Q3 2021, an estimated $1.28M.
  • Goldman Sachs first reported a position in Equillium in Q4 2019 and held it in 5 quarters.
  • Goldman Sachs's Equillium position peaked at $1.99M in Q4 2019.
  • 22 funds tracked by Wall St. Rank held Equillium as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.